日科化学(300214.SZ)发布上半年业绩，扭亏为盈至115.61万元

Core Viewpoint - The company reported significant growth in revenue and a notable reduction in net loss for the first half of 2025, indicating a positive trend in financial performance [1] Financial Performance - The company achieved operating revenue of 1.957 billion yuan, representing a year-on-year increase of 37.04% [1] - The net profit attributable to shareholders of the listed company was 1.1561 million yuan [1] - The net loss attributable to shareholders, after deducting non-recurring gains and losses, was reduced to 123,600 yuan, marking a year-on-year decrease in loss of 99.73% [1] - Basic earnings per share were reported at 0.0025 yuan [1]